A new research has found out that the clinical human trials on an Ayurvedic cancer drug can reduce cancer tumours when it will be used with routine chemotherapy. It will begin in Chennai next month.
Managing director Deepak Abhaya said, “We have tested the drug on 10 patients with encouraging results, and the second trial with 30 persons is expected to get over in March 2019, after which we will apply for drug approval from the Ayush ministry. We are hoping to market the drug by next year.”
Dr. Kattesh V Katti said, “Green nanotechnology is chemical free and can treat cancer tumours with no side effects of conventional chemotherapy. When the medicines were used in cancer patients as combined therapy along with regular chemo, tumour burden reduced by 6-8%, which is a big deal. It has no side effects like nausea or vomiting associated with chemotherapy.”
Dr. PK Julka explained, “It needs to be established that the medicine doesn’t interfere with normal treatment modalities, be it chemo, radiation, immune or hormone therapy.”
Vaidya Rajesh Kotecha said, “New drugs go to CDSCO (Central Drugs Standard Control Organization’s) Ayush vertical for review. Only after they are fully satisfied with the data, will they issue an approval.”
